Resistant Hypertension Management

Initial Assessment and Optimization

The American College of Cardiology recommends confirming true resistant hypertension by excluding pseudoresistance through ambulatory or home blood pressure monitoring to rule out white coat effect 1
The American Heart Association suggests verifying patient adherence to the current medication regimen and lifestyle modifications 1, 2
Optimal dosing of the current two-drug regimen, particularly the diuretic component, is crucial, as stated by the American College of Cardiology 1, 3
Assessing for secondary causes of hypertension that may be contributing to treatment resistance is essential, according to the American Heart Association 1
Evaluating for target organ damage (cardiac, renal, ocular, vascular) is necessary, as recommended by the American College of Cardiology 1

The American College of Cardiology recommends a three-drug foundation consisting of a renin-angiotensin system blocker, a calcium channel blocker, and an appropriately dosed diuretic based on kidney function 1, 4
Consider substituting chlorthalidone or indapamide for hydrochlorothiazide in the regimen, as these thiazide-like diuretics have shown superior 24-hour blood pressure control, according to the American Heart Association 1, 3
For patients with chronic kidney disease, ensure a loop diuretic is being used instead of a thiazide diuretic, as stated by the National Kidney Foundation 3

The American College of Cardiology recommends adding a mineralocorticoid receptor antagonist, such as spironolactone or eplerenone, as the preferred first choice as a third agent 1, 4
Monitor serum potassium and renal function closely after initiation, as advised by the American Heart Association 1, 4
Contraindicated in patients with significant renal dysfunction or hyperkalemia, according to the National Kidney Foundation 4

Schedule follow-up within 2-4 weeks to assess efficacy and tolerability, as recommended by the American College of Cardiology 2
Monitor for electrolyte abnormalities, particularly with diuretics and aldosterone antagonists, according to the American Heart Association 1, 4
Assess for orthostatic hypotension, especially in older adults and patients with diabetes, as stated by the American Diabetes Association 5, 6
Aim to achieve blood pressure control within 3 months, as recommended by the American College of Cardiology 2

Avoid dual renin-angiotensin system blockade due to increased risk of adverse events without additional benefit, as advised by the American College of Cardiology 4
Don't use combinations with similar mechanisms of action or clinical effects, according to the American Heart Association 4
Avoid therapeutic inertia - be proactive in adding or changing medications when blood pressure remains uncontrolled, as recommended by the American College of Cardiology 2
Consider fixed-dose combinations to improve adherence when possible, as stated by the National Institutes of Health
Don't overlook the importance of lifestyle modifications, which should continue alongside pharmacological therapy, according to the American Heart Association 1, 2